date:Feb 25, 2014
e addition of Lohmann Animal Health provides a unique opportunity for Elanco to expand our presence in the global poultry market and to enter the global poultry vaccine market with a solid base, established products, and global commercial and manufacturing capabilities.
Eli Lilly lowered its full-year 2014 earnings per share guidance to $2.72 to $2.80 on both a reported and non-GAAP basis. Any updates will be provided on the companys first-quarter 2014 earnings call on April 24.